Limiting e-cigarettes sales should be reasonable: Russian official

Aug.01.2022
Limiting e-cigarettes sales should be reasonable: Russian official
Russian official supports reasonable restrictions on e-cigarettes and hopes to reduce smoking rates in the country.

Alexei Kurinny, the Deputy Chairman of the Health Protection Committee in the State Duma, has stated that measures to restrict the use and sale of electronic cigarettes should be seen as reasonable rather than impossible. In an interview with Lenta.ru, he commented on the Health Ministry's push for greater regulation of these products.


Earlier, the Ministry of Health advocated for a ban on electronic cigarettes. Marine Gambaryan, director of the National Treatment and Prevention Research Center and the Tobacco Consumption Prevention and Control Center at the Ministry of Health, emphasized that it is impossible to achieve the national goal of combating tobacco consumption unless sales of electronic cigarettes are restricted.


The representative said, "I want to comprehend specifically what the restrictions entail and their intended plan of action, because I support measures to decrease the supply of various smoking blends, e-cigarettes, and classic cigarettes. However, the issue is that these measures should be reasonable.


He believes that it is necessary for Russia to implement an anti-smoking strategy, whereby the number of smokers over the next 20 years should gradually and accurately decrease to 5% of the population.


Here, we can also discuss the creation of special stores that are separate from everything else, raising the age limit for purchasing cigarettes and smoking mixtures. Perhaps there are also other issues related to flavor additives, such as in European Union countries where flavor additives have already been banned. We have yet to fully address this problem, with some things being prohibited and others not, according to Kurinny.


Earlier, Vladislav Zaslavsky, the Deputy Director of the Digital Tagging System and Product Legalization Department at the Ministry of Industry and Trade, publicly opposed the ban on electronic cigarettes. He stated that the ban would lead to the formation of a black market, making e-cigarettes uncontrollable. It is currently unclear what nicotine products will appear on the black market and how much of them there will be. Zaslavsky urged the swift implementation of a mandatory tagging system.


I'm sorry, as an AI language model, I only translate sentences. Please provide me with the sentence that needs to be translated.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Product | OXVA launches SlimStick X in Europe and the U.S., shifting from pre-filled to open-system refilling
Product | OXVA launches SlimStick X in Europe and the U.S., shifting from pre-filled to open-system refilling
OXVA has recently launched its new e-cigarette, the SlimStick X. Unlike its predecessor, the SlimStick, which used a pre-filled pod system, the SlimStick X adopts an open-system refillable design, featuring a 2ml pod, a 1.0Ω coil, and a 1400mAh battery. The product has entered online retail channels in markets including the United States, the United Kingdom, Greece, and Spain, with a price of about $23.99.
Mar.06 by 2FIRSTS.ai
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
Qnovia’s Heat-Free Inhalable Nicotine Replacement Therapy Posts Positive First-in-Human Data, Advances FDA and MHRA Filings as Funding Expands
U.S.-based medical startup Qnovia Inc. reported positive results from its first-in-human clinical trial of RespiRx, an inhalable nicotine replacement therapy (NRT) device designed to support smoking cessation.
Innovation
Feb.24
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
Patent Reveals China Tobacco Hubei Industrial Testing Animal Model for Heated Tobacco Safety Evaluation
China Tobacco Hubei Industrial Co., Ltd. has published a patent describing a laboratory method to evaluate the reproductive and developmental safety of heated tobacco products using non-human animal exposure models. The approach introduces a structured toxicological testing framework that could support safety verification, quality control, and regulatory evidence generation for heated tobacco products.
Mar.09
Belarus plans to tighten licensing for e-cigarette and e-liquid trade; Lukashenko expresses support
Belarus plans to tighten licensing for e-cigarette and e-liquid trade; Lukashenko expresses support
A report says Belarus plans to tighten, at the legislative level, the licensing of trade in electronic cigarettes and related mixtures (e-liquids). The draft law was discussed at a meeting chaired by President Alexander Lukashenko with the leadership of the Council of Ministers, according to a BelTA correspondent.
Feb.06 by 2FIRSTS.ai
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
FDA Highlights Product Characterization as a Foundational Requirement in ENDS PMTA Reviews
During its ongoing PMTA roundtable, FDA emphasized that product characterization is a foundational element in the review of electronic nicotine delivery systems (ENDS). The agency underscored the need for complete product identifying information, validation and verification of test methods on the specific product type, and the appropriate use of tobacco product master files (TPMFs) to support complex or proprietary ingredients in PMTA submissions.
Feb.10
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore to Extend Etomidate Controls and Table New Vape Legislation in 2026
Singapore will maintain etomidate’s classification under drug control laws while preparing new legislation targeting e-vaporisers, as authorities reinforce a hardline regulatory stance on vaping.
Feb.05